Metformin as a Therapeutic Target in Endometrial Cancers

about

Metformin as a Therapeutic Target in Endometrial Cancers

Item

http://www.wikidata.org/entity/Q58698115

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Metformin as a Therapeutic Target in Endometrial Cancers

@en

Metformin as a Therapeutic Target in Endometrial Cancers

@nl

type

Item

label

Metformin as a Therapeutic Target in Endometrial Cancers

@en

Metformin as a Therapeutic Target in Endometrial Cancers

@nl

prefLabel

Metformin as a Therapeutic Target in Endometrial Cancers

@en

Metformin as a Therapeutic Target in Endometrial Cancers

@nl

P1476

Metformin as a Therapeutic Target in Endometrial Cancers

@en

P2093

Christine H Kim

http://www.w3.org/2001/XMLSchema#string

Jennifer M Johnson

http://www.w3.org/2001/XMLSchema#string

Norman G Rosenblum

http://www.w3.org/2001/XMLSchema#string

Russell J Schilder

http://www.w3.org/2001/XMLSchema#string

Scott D Richard

http://www.w3.org/2001/XMLSchema#string

Teresa Y Lee

http://www.w3.org/2001/XMLSchema#string

Ubaldo E Martinez-Outschoorn

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Repurposing metformin: an old drug with new tricks in its binding pockets

Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"

HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis

Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation

Repurposing metformin for cancer treatment: current clinical studies

Molecular pathways: trafficking of metabolic resources in the tumor microenvironment

Old drug, new trick: repurposing metformin for gynecologic cancers?

P304

341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00341

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30211120

http://www.w3.org/2001/XMLSchema#string

P921

metformin

cancer research

P932

6121131

http://www.w3.org/2001/XMLSchema#string